AZ Said Leaning To Buy Out Indian Unit To Beat Pending Law
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca is considering a purchase of the 10% stake in its AstraZeneca Pharma India unit it does not already own and then remove it from India’s stock exchange.